Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
Clinical trial NCT03424629 · UNKNOWN
Trial details
- NCT number
- NCT03424629
- Sponsor
- Tianjin Ever Union Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2018-09-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.